Last reviewed · How we verify
Autologous blood transfusion with ropivacaine
Autologous blood transfusion with ropivacaine is a Local anesthetic Small molecule drug developed by Northern Orthopaedic Division, Denmark. It is currently in Phase 2 development for Pain management during and after surgery. Also known as: No other names..
Autologous blood transfusion with ropivacaine involves reinfusing a patient's own blood that has been collected and treated with ropivacaine to reduce pain.
Autologous blood transfusion with ropivacaine involves reinfusing a patient's own blood that has been collected and treated with ropivacaine to reduce pain. Used for Pain management during and after surgery.
At a glance
| Generic name | Autologous blood transfusion with ropivacaine |
|---|---|
| Also known as | No other names. |
| Sponsor | Northern Orthopaedic Division, Denmark |
| Drug class | Local anesthetic |
| Modality | Small molecule |
| Therapeutic area | Anesthesiology |
| Phase | Phase 2 |
Mechanism of action
This procedure allows for the delivery of a local anesthetic directly to the site of surgery or injury, reducing the need for systemic pain medication and minimizing side effects. Ropivacaine is a local anesthetic that works by blocking nerve signals that transmit pain to the brain.
Approved indications
- Pain management during and after surgery
Common side effects
- Nausea
- Vomiting
- Dizziness
- Headache
- Paresthesia
- Hypotension
- Bradycardia
- Respiratory depression
Key clinical trials
- AoA Guided Thoracic Epidural Analgesia for Abdominal Aortic Repair (NA)
- Autologous Blood Transfusion After Local Infiltration
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Autologous blood transfusion with ropivacaine CI brief — competitive landscape report
- Autologous blood transfusion with ropivacaine updates RSS · CI watch RSS
- Northern Orthopaedic Division, Denmark portfolio CI
Frequently asked questions about Autologous blood transfusion with ropivacaine
What is Autologous blood transfusion with ropivacaine?
How does Autologous blood transfusion with ropivacaine work?
What is Autologous blood transfusion with ropivacaine used for?
Who makes Autologous blood transfusion with ropivacaine?
Is Autologous blood transfusion with ropivacaine also known as anything else?
What drug class is Autologous blood transfusion with ropivacaine in?
What development phase is Autologous blood transfusion with ropivacaine in?
What are the side effects of Autologous blood transfusion with ropivacaine?
Related
- Drug class: All Local anesthetic drugs
- Manufacturer: Northern Orthopaedic Division, Denmark — full pipeline
- Therapeutic area: All drugs in Anesthesiology
- Indication: Drugs for Pain management during and after surgery
- Also known as: No other names.
- Compare: Autologous blood transfusion with ropivacaine vs similar drugs
- Pricing: Autologous blood transfusion with ropivacaine cost, discount & access